Related references
Note: Only part of the references are listed.Blocking interleukin-1 beta in acute and chronic autoinflammatory diseases
C. A. Dinarello
JOURNAL OF INTERNAL MEDICINE (2011)
The immune system in atherosclerosis
Goran K. Hansson et al.
NATURE IMMUNOLOGY (2011)
Atherosclerosis in ApoE-deficient mice progresses independently of the NLRP3 inflammasome
P. Menu et al.
CELL DEATH & DISEASE (2011)
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
Peter Duewell et al.
NATURE (2010)
Thioredoxin-interacting protein links oxidative stress to inflammasome activation
Rongbin Zhou et al.
NATURE IMMUNOLOGY (2010)
Cholesterol Crystals Activate the NLRP3 Inflammasome in Human Macrophages: A Novel Link between Cholesterol Metabolism and Inflammation
Kristiina Rajamaki et al.
PLOS ONE (2010)
Interleukin-1-receptor antagonist in type 2 diabetes mellitus
Claus M. Larsen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
A pilot study of IL-1 inhibition by anakinra in acute gout
Alexander So et al.
ARTHRITIS RESEARCH & THERAPY (2007)
MyD88-dependent IL-1 receptor signaling is essential for gouty inflammation stimulated by monosodium urate crystals
Chun-Jen Chen et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Gout-associated uric acid crystals activate the NALP3 inflammasome
F Martinon et al.
NATURE (2006)
NALP3 forms an IL-lβ-Processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder
L Agostini et al.
IMMUNITY (2004)
Molecular identification of a danger signal that alerts the immune system to dying cells
Y Shi et al.
NATURE (2003)
Interleukin-1-receptor antagonist in the Muckle-Wells syndrome
PN Hawkins et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
The inflammasome:: A molecular platform triggering activation of inflammatory caspases and processing of proIL-β
F Martinon et al.
MOLECULAR CELL (2002)
Share Paper
